Tizanidine hydrochloride Drugs, Importers, Informations, User, warnings, Reviews, Side, Effects, Molecular Formula C9H8ClN5S.HCl, Molecular Weight 290.17, CAS Registry Number 64461-82-1, Symptoms, Raw Material Exporters, Details, Drug Effectiveness, hydrochloride, fda, Information of Diseases, Drug, Details, Emergency, Interactions, api, Active Pharmaceutical Ingredients, Dosage, Taj Pharmaceuticals LTd.

Sitemap | Contact Us

Welcome To Taj Pharmaceuticals Ltd API

Tiagabine-Hcl

India

Latin America/ Caribbean

Africa & Middle East

Asia

Russia

Europe

Tizanidine Hcl Manufacturers in India Suppliers Tizanidine Hcl Exporters Distributors Tizanidine Hcl api active pharmaceuticals ingredients Tizanidine Hcl manufacturers Side Effects bulk drugs raw material Tizanidine Hcl companies Side Effects Importers Tizanidine Hcl Tizanidine Hcl Exporters Tizanidine Hcl exporters FDA Tizanidine Hcl DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Tizanidine Hydrochloride manufacturing pharmaceutical drugs pharmaceutical intermediates Tizanidine Hydrochloride pharmaceutical chemicals pharmaceutical raw materials Tizanidine Hydrochloride active pharmaceutical ingredients Tizanidine Hydrochloride committee active pharmaceutical ingredients manufacturer Tizanidine Hydrochloride Active Pharmaceutical Ingredients manufacturer Tizanidine Hydrochloride exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Tizanidine Hcl, Tizanidine Hcl manufacturer India, Tizanidine Hcl product, Tizanidine Hcl products, Api preparation, Certificate of Analysis API manufacturer product, Tizanidine Hcl anti ulcer product, Certificate of Origin COA Tizanidine Hcl COS Tizanidine Hcl, pharmaceutical generic, pharmaceutical drug, medical, Tizanidine Hcl pharma healthcare, pharma patents, contract MSDS manufacturing Trader Tizanidine Hcl pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Tizanidine Hcl expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Tizanidine Hcl DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Tizanidine Hcl ingredients, api, HIV Tizanidine Hcl, tablets, capsules, syrup & protein Tizanidine Hcl powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Tizanidine Hcl gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Tizanidine Hcl WHO, UKMHRA Approval

	PRODUCT LIST
	Home
	API >>>
	Pharmaceuticals API List
	Chemicals
	Manufacturing
	Product Development
	Product Search
	Agro Chemicals
	Custom Pharma Services
	Contact Us

tizanidine hcl research

HOME >> API >> API List 3 >> Tizanidine Hcl >> Interaction

INTERACTION
Tizanidine Hcl CAS Registry Number 64461-82-1

Tell your doctor of all prescription and nonprescription medications you may take, especially of: blood pressure drugs (e.g., water pills, clonidine, methyldopa, guanabenz, guanfacine), MAO inhibitors (e.g., linezolid, furazolidone, phenelzine, selegiline), sleep medicines, sedatives (e.g., diazepam), tranquilizers, anti-anxiety drugs, narcotic pain relievers (e.g., codeine, morphine), barbiturates (e.g., phenobarbital), certain antihistamines (e.g., diphenhydramine), other muscle relaxants (e.g., cyclobenzaprine), certain antidepressants (e.g., imipramine, amitriptyline, trazodone), phenothiazine psychiatric drugs (e.g., chlorpromazine), birth control pills, rofecoxib.

Acetaminophen: Tizanidine delayed the Tmax of acetaminophen by 16 minutes. Acetaminophen did not affect the pharmacokinetics of tizanidine.

Alcohol: Alcohol increased the AUC of tizanidine by approximately 20% while also increasing its Cmax by approximately 15%. This was associated with an increase in side effects of tizanidine. The CNS depressant effects of tizanidine and alcohol are additive.

Fluvoxamine: Clinically significant hypotension (decreases in both systolic and diastolic pressure) has been reported with concomitant administration of fluvoxamine following single doses of 4 mg.

Caution is recommended when considering concomitant use of tizanidine with other inhibitors of CYP1A2, such as, antiarrhythmics (amiodarone, mexiletine, propafenone), cimetidine, fluoroquinolones (ciprofloxacin, norfloxacin), rofecoxib, oral contraceptives, and ticlopidine.

Oral Contraceptives: No specific pharmacokinetic study was conducted to investigate interaction between oral contraceptives and tizanidine, but retrospective analysis of population pharmacokinetic data following single and multiple dose administration of 4 mg tizanidine showed that women concurrently taking oral contraceptives had 50% lower clearance of tizanidine than women not on oral contraceptives.

Information Associated with Product:

DRUG DESCRIPTION

DOSAGE

SIDE EFFECTS

PRECAUTIONS

INTERACTION >>

CONSUMER INFORMATION

PDF DOWNLOAD

WORD DOCUMENT


Product Enquiry	Product Quotation	Sample Request	Place Your Order

Taj Pharmaceuticals API Logo

Investor Relations Feedback Contact Worldwide Sitemap

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.